Fundamental and Clinical Pharmacology · 2019 · 35 citations · 22 references
Life SciencesCancer BiologyOncologyApoptosisCarcinogenesisMolecular OncologyApoptosis In CancerApoptosis RegulationCancer Cell SignalingMalignant NeoplasmsMicrorna BiologyMicrorna-mediated RegulationApoptosis-regulating MicrornasCancer Cell ApoptosisCell Viability AssaysMicrorna In CancerMicrorna Regulation In CancerMicrorna Regulation Of ApoptosisProtein Kinase C SignalingWestern Blot Analysis
Breast cancer (BC) is the most common cause of death in women throughout the world. MicroRNAs (miRNAs, miR) have been identified as key regulators in carcinogenesis of several cancers, including BC. MicroRNA-216a (miR-216a) is downregulated in several cancers. Here, we evaluated the effects of miRNA-216a on breast cancer cells and the underlying mechanisms. miR-216a level was quantified by real-time RT-PCR. Cell viability was analyzed by MTT assay. Wound-healing assay was performed for detection of cell migration. Apoptosis was detected by TUNEL and caspase-3 activity assay. Moreover, the level of protein expression was determined by Western blot. We found that miR-216a expression was remarkably decreased in both human BC tissues and MCF-7 cells. miR-216a overexpression dramatically suppressed the migration and promoted the apoptosis in cultured MCF-7 cells. We validated PKCα (protein kinase C alpha, PRKCA) as a direct target of miR-216a. Knockdown of PKCα induced apoptosis and inhibited migration in cultured MCF-7 cells which were reversed by miR-216a inhibitor. Moreover, the level of miR-216a is negatively correlated with PKCα in cell lines. Our results collectively suggest that miR-216a suppressed migration and promoted apoptosis in breast cancer cells by targeting PKCα. These findings indicate that manipulation of miR-216a expression may represent a novel therapeutic strategy in the treatment of breast cancer.
22
MicroRNA-328 Contributes to Adverse Electrical Remodeling in Atrial Fibrillation
Yanjie Lu, Ying Zhang, Ning Wang et al. · Circulation · 2010 · 443 citations · Full text
MiR-485-3p and miR-485-5p suppress breast cancer cell metastasis by inhibiting PGC-1α expression
Changjie Lou, Min Xiao, Shi Cheng et al. · Cell Death and Disease · 2016 · 155 citations · Full text
Medicine, Cell Biology, Oncology +17
PKCα expression is a marker for breast cancer aggressiveness
Gry Kalstad Lønne, Louise Cornmark, Iris Zahirovic et al. · Molecular Cancer · 2010 · 108 citations · Full text
Medicine, Cancer Biology, Oncology +14